Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a Centralized Approach

被引:33
|
作者
Smith, Harrison B. [1 ]
Ward, Ralph [2 ,3 ]
Frazier, Cassie [2 ]
Angotti, Jonathan [1 ]
Tanner, Nichole T. [1 ,3 ]
机构
[1] Med Univ South Carolina, Thorac Oncol Res Grp, Div Pulm & Crit Care, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Publ Hlth, Charleston, SC 29425 USA
[3] Ralph H Johnson Vet Affairs Hosp, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC 29401 USA
关键词
adherence; lung cancer; lung cancer screening; thoracic oncology; COMPUTED-TOMOGRAPHY; CHEST PHYSICIANS; IMPLEMENTATION; SELECTION; PROGRAMS; COLLEGE; IMPACT;
D O I
10.1016/j.chest.2021.09.002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: To recognize fully the benefit of lung cancer screening (LCS), annual adherence must approach the high levels seen in the National Lung Screening Trial. Emerging data suggest that annual adherence is poor and that a centralized approach to screening improves adherence. RESEARCH QUESTIONS: Do differences in adherence exist between a centralized and decentralized approach to LCS within a hybrid program and what are predictors of adherence? STUDY DESIGN AND METHODS: A retrospective evaluation of a single-center hybrid LCS program was conducted to compare outcomes including patient eligibility and adherence between the centralized and decentralized approaches. Patient demographics and outcomes were compared between those screened with a centralized and decentralized approach and between adherent and nonadherent patients using two-sample t tests, chi(2) tests, or analyses of variance, as appropriate. Annual adherence analysis was conducted using data from patients who remained eligible for screening with a baseline Lung CT Screening Reporting and Data System (Lung-RADS) score of 1 or 2. Logistic regression was used to estimate the association between adherence and the primary exposure, adjusting for potential confounders. RESULTS: A cohort of 1,117 patients underwent baseline low-dose CT imaging. Two hundred eleven patients (19%) were ineligible by United States Preventative Services Task Force criteria and most (90%) were screened with the decentralized approach. After exclusions, 765 patients with Lung-RADS score of 1 or 2 remained eligible for annual screening. Overall adherence was 56%; however, adherence in the centralized program was 70%, compared with 41% with the decentralized approach (P <.001). Individuals screened in a decentralized approach were 73% less likely to be adherent (OR, 0.27; 95% CI, 0.19-0.37). A greater proportion of patients with three or more comorbidities were screened outside the centralized program. INTERPRETATION: Those screened using a centralized approach were more likely to meet eligibility criteria for LCS and more likely to return for annual screening than those screened using a decentralized approach.
引用
收藏
页码:818 / 825
页数:8
相关论文
共 50 条
  • [31] Height growth in children with asthma treated with guideline-recommended dosages of fluticasone and electronically assessed adherence
    Wardenier, Nele R. A.
    Klok, Ted
    de Groot, Eric P.
    Brand, Paul L. P.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (07) : 637 - 639
  • [32] ADHERENCE TO GUIDELINE-RECOMMENDED CUFF-LEAK TESTING IN THE MEDICAL ICU: A QUALITY IMPROVEMENT STUDY
    King, Kourtney
    Disilvio, Briana
    Nasrullah, Adeel
    Schorr, Rebecca
    Dumont, Tiffany
    [J]. CHEST, 2020, 158 (04) : 1300A - 1300A
  • [33] Adherence to Guideline-Recommended Physical Activity Nullifies Mortality Risks of Extended Sitting in Adults With Diabetes
    Dai, Wen
    Albrecht, Sandra S.
    [J]. CIRCULATION, 2024, 149
  • [34] Guideline-recommended incorporation of biomarker testing results in metastatic colorectal cancer therapy
    Freml, Jared
    Delate, Thomas
    Hermosillo-Rodriguez, Jesus
    [J]. PERSONALIZED MEDICINE, 2020, 17 (03) : 185 - 194
  • [35] Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients
    Wu, Ann Chen
    Mazor, Kathleen M.
    Ceccarelli, Rachel
    Loomer, Stephanie
    Lu, Christine Y.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2017, 7 (04):
  • [36] Barriers and facilitators to implementation and sustainment of guideline-recommended depression screening for patients with breast cancer in medical oncology: a qualitative study
    Hahn, Erin E.
    Munoz-Plaza, Corrine E.
    Lyons, Lindsay Joe
    Lee, Janet S.
    Pounds, Dana
    La Cava, Shannon
    Brasfield, Farah M.
    Durna, Lara N.
    Kwan, Karen W.
    Beard, David B.
    Ferreira, Alexander
    Gould, Michael K.
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (08)
  • [37] Barriers and facilitators to implementation and sustainment of guideline-recommended depression screening for patients with breast cancer in medical oncology: a qualitative study
    Erin E. Hahn
    Corrine E. Munoz-Plaza
    Lindsay Joe Lyons
    Janet S. Lee
    Dana Pounds
    Shannon La Cava
    Farah M. Brasfield
    Lara N. Durna
    Karen W. Kwan
    David B. Beard
    Alexander Ferreira
    Michael K. Gould
    [J]. Supportive Care in Cancer, 2023, 31
  • [38] ADHERENCE TO US PREVENTATIVE SERVICES TASKFORCE GUIDELINES FOR LUNG CANCER SCREENING IN AN INSTITUTION WITHOUT A CENTRALIZED LUNG CANCER SCREENING PROGRAM
    Alkhunaizi, Mansour
    Velasco, Maria
    Chan, Stanley
    Gago, Jorge
    Bujarski, Stephen
    [J]. CHEST, 2021, 160 (04) : 1613A - 1613A
  • [39] The Imperative of Equal Funding for Studies That Evaluate Any of the Evidence-Based, Guideline-Recommended Colorectal Cancer Screening Tests
    Allison, James E.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (12) : 1269 - 1271
  • [40] Timely testing: who needs to do what differently to improve adherence to guideline-recommended glycaemic monitoring?
    McHugh, Sheena
    O'Neill, Kate
    Kearney, Patricia M.
    [J]. BMJ QUALITY & SAFETY, 2021, 30 (09) : 694 - 696